Pascale Witz work email
- Valid
- Valid
- Valid
- Valid
- Valid
- Valid
- Valid
Pascale Witz personal email
Pascale Witz phone numbers
Board Director and former CEO with over 30 years of successful experience in the life sciences industry. As former EVP of the Pharma Divisions at Sanofi, Pascale Witz led the worldwide businesses of Cardiovascular, Diabetes, Oncology, Immuno-Inflammation, Renal, Biosurgery and Consumer Healthcare ($15Bn Rev). Prior to this, she was President & CEO of GE’s $2Bn Pharma-diagnostics.Currently serves on the board of publicly listed companies Fresenius Medical Care, Revvity and Regulus Therapeutics, and previously of Horizon Therapeutics and Tesaro Bio, as well as Chair or Board Director of PE-backed companies (incl. Arsenal Capital Partners, Montagu, Francisco Partners, and Leonard Green). Also serves as Chair of the Nomination and Compensation Committee at Insead, as Senior Advisor to Bain Consulting, and advisor & angel investor in early-stage companies.An experienced Chair of Audit, Compensation, Nomination Committee, she creates value for stakeholders and partners.A molecular biologist and an engineer with an MBA from INSEAD, Pascale has extensive experience and expertise in various sectors including Pharma, Biotech, MedTech, and Digital Health, and has had first-hand operational and commercial leadership based out of the US, the UK and Europe. She was part of the Fortune magazine top 20 Women EMEA list in 2014 and 2015, and authored a book “Tech: the Healthcare Revolution” in 2021.She is fluent in French, English, and German.
-
ChairAugustine TherapeuticsNew York, Ny, Us -
ChairRti Surgical® Apr 2021 - PresentAlachua, Fl, UsRTI Surgical is a CDMO focused on Biologic & Tissues implants - Allograft and Xenograft.Developper of Cortiva® and Tutoplast®Privately owned -
Board Member, Chair Audit CommitteeFresenius Medical Care May 2016 - PresentBad Homburg, Frankfurt, DeFresenius Medical Care is a world leading dialysis company, one of the largest operators of dialysis clinics in the US, also developing and commercializing dialysis machines & dialyzers. Chair of Audit Committee -
Board Member, Audit Committee, Compensation CommitteeRevvity Oct 2017 - PresentWaltham, Massachusetts, UsRevvity (fka Perkin Elmer) is a Life Sciences and Diagnostics company focused on selling to the pharmaceutical and biotechnology industries. Renamed in 2022, after its sales of the non core activities to New Mountain Capital (Applied, Food and Enterprise systems activities)Revvity's transformation was enabled by strategic acquisitions: BioLegend (2021), EuroImmun (2017), Horizon Discovery (2020), Tulip Diagnostics (2019)Audit Committee, Compensation Committee -
Board Member, Compensation CommitteeRegulus Therapeutics Jun 2017 - PresentSan Diego, Ca, UsCompensation committee (2019-) ; Audit Committee 2017-2018 -
Board MemberArkuda Therapeutics Nov 2019 - PresentWatertown, Massachusetts, UsArkuda Therapeutics is a Biotech company applying specialized expertise and deep knowledge of lysosomal biology to discover therapies for Neurodegenerative diseaseCompensation Committee -
Board Member, Chair Nomination & Compensation CommitteeInsead Mar 2020 - PresentFontainebleau, Singapore, Abu Dhabi, San Francisco, Oo -
Board Member, Audit CommitteeGlobal Alzheimer'S Platform Foundation Sep 2016 - PresentGAP Foundation's mission is to accelerate clinical trials for Alzheimer Disease, helping pharmaceutical companies recruiting patients faster. -
Founder, President & CeoPwh Advisors Oct 2016 - Present
-
Board MemberFrench-American Foundation - France Jun 2014 - PresentParis, Fr -
Seed InvestorEmbleema 2018 - PresentNew York, Ny, Us -
Board Member, Audit Committee, Nomination & Governance CommitteeHorizon Aug 2017 - Nov 2023Dublin, Ireland, IeAudit Committee, Nomination & Governance CommitteeAcquisition by Amgen for $28Bn, closed Oct 2023 -
Board MemberPhilips Capsule Jul 2019 - Jan 2021Cambridge, Massachusetts, UsCapsule Technologies - leading global provider of Medical Device Integration (MDI) and Information solutions for healthcare providers; providing clinical surveillance and patient monitoring capabilities to help simplify clinical workflow and gain actionable insights.A Francisco Partners's company, sold to Philips in Jan 2021 - Deal of year in PE Mid Cap 2021. -
Board Member, Audit Committee, Compensation CommitteeTesaro, Inc. 2018 - 2019Waltham, Massachusetts, UsAudit Committee ; Compensation CommitteeAcquired by GSK Jan 2019 for $5.1Bn -
Board MemberGroupe Savencia Apr 2016 - Apr 2018Viroflay, Ile-De-France, Fr -
Executive Vice President Diabetes & CardiovascularSanofi Jul 2015 - Sep 2016Paris, France, Fr -
Executive Vice President, Pharma & Consumer HealthcareSanofi Jul 2013 - Sep 2015Paris, France, FrDiabetes, Cardiovascular, Oncology, ImmunoInflammation (BioLogics for Dermato / Asthma / Rheumatoid Arthritis), Renal, Biosurgery, Consumer Healthcare
-
President & Ceo, Pharmaceutical DiagnosticsGe Healthcare Mar 2009 - Jun 2013Chicago, UsPresident and CEO of GE Healthcare's fully integrated pharmaceutical company (formerly Amersham Health), $2Bn revenues, 5000 employee, direct distribution in all 3 continents, 10 plants globally, Research & Development in US/ UK /EU / AsiaDirect oversight & reporting of all functions, including R&D, Industrial Affairs, CommercialRegained profitability while going thru generic events, with 20% annual growth in emerging markets, and margin improvement; Managed three FDA approvals and product launches for Cardiovascular diseases, Alzheimer’s disease and Parkinson’s disease; Strengthened the R&D functions, with a particular focus on the effectiveness of the Clinical Development, Regulatory Affairs, Pharmacovigilance and Medical Affairs; Launched a major plants footprint & supply optimization project, in a highly regulated environment (production of radio-labelled compounds)GE CEO achievement award in 2010.2011- 2012, as part of the diversification strategy of GE Healthcare, led the acquisitions and integration of 2 Molecular Diagnostics CLIA laboratories, serving primarily Pathologists and Oncologists.Board director of Nihon-MediPhysics co. Ltd, developing/ manufacturing/ commercializing Therapeutics and Medical Devices for Nuclear Medicine in JapanBoard Director Onyx LLC: development of a Digital Pathology Product (Hardware & Software)During my whole GE tenure I was an active leader in the GE Women’s Network, and made important contributions to the development, motivation and retention of female employees at GE. -
President & Ceo, Interventional │Medical Devices │ Medtech │ CardiologyGe Healthcare Nov 2007 - Feb 2009Chicago, Us
-
Various Leadership Roles │Medical Devices │ Medtech │ CardiologyGe Healthcare 1996 - Nov 2007Chicago, UsPascale started as Global Product Manager, Vascular in the Interventional Business in 1996 before becoming Global Marketing Manager for Conventional Radiology products in 1999. From 2000 to 2007, Pascale held several General Management roles within GE Healthcare EMEA: VP Six Sigma and Quality, VP e-Business and CIO, General Manager Nuclear Medicine and PET EMEA, VP Services Sales & Marketing for all imaging products EMEA, and General Manager Computed Tomography EMEA. As President and CEO, Interventional, Pascale led the CathLab & Interventional Radiology, and the minimally invasive monitoring businesses globally (ca $1Bn)
-
Co-Founder And Executive Board MemberCercle Interelles 2001 - 2007Rueil-Malmaison, Île-De-France, FrCo-Founder of the Cercle in 2001, a network of women's network of High Tech companies, focusing on the development of gender diversity.The Cercle today includes 11+ companies: Air Liquide, Areva, Assystem, CEA, GE, IBM, Intel, Lenovo, Nexter, Orange et Schlumberger. http://www.interelles.com -
Marketing Manager │ Pharmaceuticals│ Medical Devices│Quality│IndustrialBecton Dickinson Feb 1991 - Jul 1995Franklin Lakes, New Jersey, Us -
Phd StudentCnrs - Centre National De La Recherche Scientifique / National Institute For Scientific Research 1989 - 1991Paris, FrMolecular Biology. Isolation and cloning of a 5HT2 serotonin receptor in the drosophila brain.
Pascale Witz Skills
Pascale Witz Education Details
-
InseadEconomics & Marketing -
Insa Lyon - Institut National Des Sciences Appliquées De LyonMolecular Biology / Biochemistry / Life Sciences
Frequently Asked Questions about Pascale Witz
What company does Pascale Witz work for?
Pascale Witz works for Augustine Therapeutics
What is Pascale Witz's role at the current company?
Pascale Witz's current role is Chair.
What is Pascale Witz's email address?
Pascale Witz's email address is pw****@****rma.com
What is Pascale Witz's direct phone number?
Pascale Witz's direct phone number is +190898*****
What schools did Pascale Witz attend?
Pascale Witz attended Insead, Insa Lyon - Institut National Des Sciences Appliquées De Lyon.
What skills is Pascale Witz known for?
Pascale Witz has skills like Strategy, Medical Devices, Pharmaceutical Industry, Healthcare.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial